Table 1

Baseline characteristics

CharacteristicOestrogen (n=50)No treatment (n=50)Overall
(n=100)
Age, years*<6521 (42%)21 (42%)42 (42%)
≥6529 (58%)29 (58%)58 (58%)
Mean (SD)65.7 (8.2)65.9 (8.4)65.8 (8.3)
Ethnic groupWhite45 (90%)43 (86%)88 (88%)
Asian2 (4%)3 (6%)5 (5%)
Black3 (6%)1 (2%)4 (4%)
Mixed0 (-)2 (4%)2 (5%)
Other ethnic group0 (-)1 (2%)1 (1%)
BMI (mg/k2)Mean (SD)28.1 (5.1)28.2 (5.9)28.2 (5.5)
Missing (N)279
Parity*≤227 (54%)26 (52%)53 (53%)
>223 (46%)24 (48%)47 (47%)
Maximum stage of prolapse*I7 (14%)7 (14%)14 (14%)
II23 (46%)23 (46%)46 (46%)
III/IV20 (40%)20 (40%)40 (40%)
Concomitant continence surgery performed*N (%)2 (4%)3 (6%)5 (5%)
Previous operation for prolapseN (%)4 (8%)4 (8%)8 (8%)
 AnteriorNo. of repairs, median (IQR)1 (1–1)1 (1–1)1 (1–1)
 PosteriorNo. of repairs, median (IQR)1 (1–1)1 (1–1)1 (1–1)
HysterectomyN (%)12 (24%)8 (16%)20 (20%)
Vaginal pessary/ring currently in placeN (%)5 (10%)8 (16%)13 (13%)
Physiotherapy treatment for prolapse/urinary incontinence in last 12 monthsN (%)8 (16%)10 (20%)18 (18%)
Drug treatment for urinary incontinenceN (%)0 (-)4 (8%)4 (4%)
Treatment for overactive bladderN (%)0 (-)0 (-)0 (-)
  • *Minimisation variable.

  • BMI, body mass index.